NCT05542160已完成不适用
Effectiveness of IRK-19® on Body Weight Control
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Anthropometric measurement
研究概览
简要总结
This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract (IRK-19®) on weight management.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 20 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •BMI: 25-30 kg/m2
- •Waistline circumference: ˃ 80 cm
排除标准
- •Pregnant women or preparing for pregnancy.
- •Lactating women.
- •Women gave birth 6 months before the study.
- •Subject uses diuretic, corticosteroids, anti-depressant medications, or antipsychotic medications.
- •Subject has undertaken obesity-related surgeries within one year prior to the study or other surgeries within six months prior to the study.
- •Change of body weight of subject is over 5% within 3 months before the study.
- •Subject has serious diseases (e.g., cardiovascular diseases).
- •Cancer patient.
- •Subject has engaged in another study within 3 months before the study.
- •Subject uses another dietary supplement related to weight management during the study.
结局指标
主要结局
Anthropometric measurement
时间窗: Week 12
Body weight
Body composition analysis
时间窗: Week 12
Body fat
Biochemistry
时间窗: Week 12
Total cholesterol
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
DBRPC Study to Evaluate the Efficacy and Safety of IQP-AE-103 in Overweight and Moderately Obese SubjectsOverweightObesityNCT04086797Perrigo CSCI178
已完成
3 期
Efficacy and Safety of Zenoctil in Reducing Body WeightOverweightNCT01423617InQpharm Group92
已完成
2 期
An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese SubjectsObesityNCT01666691Zafgen, Inc.160
已完成
1 期
Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese SubjectsObesityNCT00909766Bristol-Myers Squibb113
已完成
4 期
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight SubjectsWeight LossNCT04375696Certmedica International GmbH150